CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 115 filers reported holding CHINA BIOLOGIC PRODS INC in Q4 2015. The put-call ratio across all filers is 1.08 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $613,000 | -78.1% | 6,825 | -71.9% | 0.14% | -75.2% |
| Q2 2015 | $2,801,000 | -11.3% | 24,325 | -26.4% | 0.55% | -17.5% |
| Q1 2015 | $3,157,000 | -21.7% | 33,050 | -44.9% | 0.67% | -26.2% |
| Q4 2014 | $4,034,000 | +22.7% | 60,000 | -1.5% | 0.91% | +13.5% |
| Q3 2014 | $3,288,000 | +74.2% | 60,934 | +43.6% | 0.80% | +96.1% |
| Q2 2014 | $1,887,000 | – | 42,439 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPQ Asia Capital Ltd | 287,277 | $35,760,000 | 28.32% |
| WARBURG PINCUS LLC | 6,674 | $830,780,000 | 13.45% |
| Ariose Capital Management Ltd | 238,841 | $27,689,000 | 7.56% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 12,600 | $1,568,000 | 4.48% |
| RUDMAN ERROL M | 37,001 | $4,606,000 | 3.72% |
| INDUS CAPITAL PARTNERS, LLC | 245,237 | $30,527,000 | 2.89% |
| Ativo Capital Management LLC | 93,784 | $11,674,000 | 2.70% |
| OBERWEIS ASSET MANAGEMENT INC/ | 63,305 | $7,880,000 | 2.27% |
| Point72 Hong Kong Ltd | 31,500 | $3,921,000 | 2.14% |
| Cormorant Asset Management, LP | 112,867 | $14,050,000 | 1.55% |